product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Bcl-w (31H4) Rabbit mAb
catalog :
2724
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
31H4
reactivity :
human, mouse, rat
application :
western blot, western blot knockout validation
citations: 5
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; mouse; loading ...; fig s2a
  • western blot; human; loading ...; fig 7a
Adams C, Kim A, Mitra R, Choi J, Gong J, Eischen C. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017;127:635-650 pubmed publisher
  • western blot; human; fig 5
O Neill K, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973-88 pubmed publisher
  • western blot; human; fig 1
  • western blot; mouse; fig 1
Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
Minami D, Takigawa N, Takeda H, Takata M, Ochi N, Ichihara E, et al. Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells. Mol Cancer Res. 2013;11:140-8 pubmed publisher
Zall H, Weber A, Besch R, Zantl N, Hacker G. Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1. Mol Cancer. 2010;9:164 pubmed publisher
product information
SKU :
2724S
Product-Name :
Bcl-w (31H4) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Western blot
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
18
Host :
Rabbit
Target :
Bcl-W
Primary-Protein :
BCL2L2
Alt-Names :
Apoptosis regulator Bcl-W,B2CL2,BCL-W,BCL2-like 2,BCL2-like 2 protein,BCL2L2,BCLW,Bcl-2-like protein 2,Bcl2-L-2,KIAA0271
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.